Publication Cover
Chronobiology International
The Journal of Biological and Medical Rhythm Research
Volume 33, 2016 - Issue 4
1,531
Views
56
CrossRef citations to date
0
Altmetric
Reviews

Sleep and cancer: Synthesis of experimental data and meta-analyses of cancer incidence among some 1,500,000 study individuals in 13 countries

, , , , &

References

  • Akerstedt T, Wright KP Jr. (2009). Sleep Loss and Fatigue in Shift Work and Shift Work Disorder. Sleep Med Clin 4:257–71.
  • Al Khalaf MM, Thalib L, Doi SA. (2011). Combining heterogenous studies using the random-effects model is a mistake and leads to inconclusive meta-analyses. J Clin Epidemiol 64:119–23.
  • Basner M, Glatz C, Griefahn B, Penzel T, et al. (2008). Aircraft noise: effects on macro- and microstructure of sleep. Sleep Med 9:382–7.
  • Basner M, Muller U, Elmenhorst EM, Kluge Gand, Griefahn B. (2008). Aircraft noise effects on sleep: a systematic comparison of EEG awakenings and automatically detected cardiac activations. Physiol Meas 29:1089–103.
  • Bizzarri M, Proietti S, Cucina A, et al. (2013). Molecular mechanisms of the pro-apoptotic actions of melatonin in cancer: a review. Expert Opin Ther Targets 17:1483–96.
  • Blask DE, Brainard GC, Dauchy RT, Hanifin JP, et al. (2005). Melatonin-depleted blood from premenopausal women exposed to light at night stimulates growth of human breast cancer xenografts in nude rats. Cancer Res 65:11174–84.
  • Bouatia-Naji N, Bonnefond A, Cavalcanti-Proenca C, Sparso T, et al. (2009). A variant near MTNR1B is associated with increased fasting plasma glucose levels and type 2 diabetes risk. Nature genetics 41:89–94.
  • Cairns BJ, Travis RC, Wang XS, Reeves GK, et al. (2012). A short-term increase in cancer risk associated with daytime napping is likely to reflect pre-clinical disease: prospective cohort study. Br J Cancer 107:527–30.
  • Cos S, Fernandez R, Guezmes A, Sanchez-Barcelo EJ. (1998). Influence of melatonin on invasive and metastatic properties of MCF-7 human breast cancer cells. Cancer Res 58:4383–90.
  • Czeisler CA. (2013). Perspective: casting light on sleep deficiency. Nature 497:S13.
  • Czeisler CA. (2015). Duration, timing and quality of sleep are each vital for health, performance and safety. Sleep Health 1:5–8.
  • Czeisler CA, Chiasera AJ, Duffy JF. (1991). Research on sleep, circadian rhythms and aging: applications to manned spaceflight. Exp Gerontol 26:217–32.
  • Davidson AJ, Sellix MT, Daniel J, Yamazaki S, Menaker M, et al. (2006). Chronic jet-lag increases mortality in aged mice. Curr Biol 16:R914–16.
  • Davis S, Mirick DK. (2006). Circadian disruption, shift work and the risk of cancer: a summary of the evidence and studies in Seattle. Cancer causes & control : CCC17:539–45.
  • Depner CM, Stothard ER, Wright KP Jr. (2014). Metabolic consequences of sleep and circadian disorders. Curr Diab Rep 14:507.
  • Duval S, Tweedie R. (2000). Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 56:455–63.
  • Egger M, Smith GD, Schneider M, Minder C. (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629–34.
  • Erren TC. (2002). Does light cause internal cancers? The problem and challenge of an ubiquitous exposure. Neuro Endocrinol Lett 23 Suppl 2:61–70.
  • Erren TC. (2012). Sleep duration and cancer risk: time to use a “sleep-years” index? Cancer Causes Control 23:1399–403.
  • Erren TC. (2013). Re: “Self-reported sleep duration, sleep quality, and breast cancer risk in a population-based case-control study”. Am J Epidemiol 177:1020–21.
  • Erren TC, Falaturi P, Reiter RJ. (2010). Research into the chronodisruption-cancer theory: the imperative for causal clarification and the danger of causal reductionism. Neuro Endocrinol Lett 31:1–3.
  • Erren TC, Groß J. (2015). Re: Fragmentation and Stability of Circadian Activity Rhythms Predict Mortality: The Rotterdam Study. Sleep epidemiology: proposing an index of accumulated sleep disruption. Am J Epidemiol 15:185–6.
  • Erren TC, Groß J. (2015). Civil time ≠ biological time: Recent options for empirically testing possible effects of chronodisruption. Chronobiology International 32:697–8.
  • Erren TC, Morfeld P. (2013). Shift work and cancer research: a thought experiment into a potential chronobiological fallacy of past and perspectives for future epidemiological studies. Neuro Endocrinol Lett 34:282–6.
  • Erren TC, Morfeld P. (2014). Computing chronodisruption: how to avoid potential chronobiological errors in epidemiological studies of shift work and cancer. Chronobiol Int 31:589–99.
  • Erren TC,Reiter RJ. (2008). A generalized theory of carcinogenesis due to chronodisruption. Neuro Endocrinol Lett 29:815–21.
  • Erren TC, Reiter RJ. (2009). Defining chronodisruption. J Pineal Res 46:245–7.
  • Erren TC, Reiter RJ. (2013). Revisiting chronodisruption: when the physiological nexus between internal and external times splits in humans. Naturwissenschaften 100:291–8.
  • Erren TC, Reiter RJ, Piekarski C. (2003). Light, timing of biological rhythms, and chronodisruption in man. Naturwissenschaften 90:485–94.
  • Erren TC, Reiter RJ. (2015). Melatonin: a universal time messenger. Neuro Endocrinol Lett 36:187–92.
  • Erren TC, Slanger TE, Groß JV, Reiter RJ. (2015). Melatonin, sleep, and prostate cancer in elderly men: study, hypothesis development, and icelandic options. Eur Urol 67:195–7.
  • Erren TC, Slanger TE, Groß JV, Reiter RJ. (2015). New generation mouse model: What about circadian diversity? Environmental Health Perspectives 123:A232.
  • Ferrie JE, Kumari M, Salo P, Singh-Manoux A, et al. (2011). Sleep epidemiology--a rapidly growing field. Int J Epidemiol 40:1431–7.
  • Filipski E, Delaunay F, King VM, Wu MW, et al. (2004). Effects of chronic jet lag on tumor progression in mice. Cancer Res 64:7879–85.
  • Filipski E, King VM, Li X, Granda TG, et al. (2002). Host circadian clock as a control point in tumor progression. J Natl Cancer Inst 94:690–7.
  • Foster RG, Hankins MW. (2007). Circadian vision. Curr Biol 17:R746–51.
  • Foster RG, Peirson SN, Wulff K, Winnebeck E, et al. (2013). Sleep and circadian rhythm disruption in social jetlag and mental illness. Prog Mol Biol Transl Sci 119:325–46.
  • Foster RG, Wulff K. (2005). The rhythm of rest and excess. Nat Rev Neurosci 6:407–14.
  • Fu L, Lee CC. (2003). The circadian clock: pacemaker and tumour suppressor. Nat Rev Cancer 3:350–61.
  • Gangwisch JE, Malaspina D, Boden-Albala B, Heymsfield SB. (2005). Inadequate sleep as a risk factor for obesity: analyses of the NHANES I. Sleep 28:1289–96.
  • Girschik J, Heyworth J, Fritschi L. (2010). Re: Night-shift work and breast cancer risk in a cohort of Chinese women. Am J Epidemiol 172: 865-6;author reply 867–8.
  • Girschik J, Heyworth J, Fritschi L. (2013). Self-reported sleep duration, sleep quality, and breast cancer risk in a population-based case-control study. Am J Epidemiol 177:316–27.
  • Graham PL, Moran JL. (2012). Robust meta-analytic conclusions mandate the provision of prediction intervals in meta-analysis summaries. J Clin Epidemiol 65:503–10.
  • Greene MW. (2012). Circadian rhythms and tumor growth. Cancer Lett 318:115–23.
  • Groeger JA, Zijlstra FR, Dijk DJ. (2004). Sleep quantity, sleep difficulties and their perceived consequences in a representative sample of some 2000 British adults. J Sleep Res 13:359–71.
  • Hardeland R, Madrid JA, Tan DX, Reiter RJ. (2012). Melatonin, the circadian multioscillator system and health: the need for detailed analyses of peripheral melatonin signaling. J Pineal Res 52:139–66.
  • Hermida RC. (2007). Ambulatory blood pressure monitoring in the prediction of cardiovascular events and effects of chronotherapy: rationale and design of the MAPEC study. Chronobiol Int 24:749–775.
  • Hermida RC, Ayala DE, Mojon A, Fernandez JR. (2010). Influence of circadian time of hypertension treatment on cardiovascular risk: results of the MAPEC study. Chronobiol Int 27:1629–51.
  • Hermida RC, Ayala DE, Mojon A, Fernandez JR. (2013). Blunted sleep-time relative blood pressure decline increases cardiovascular risk independent of blood pressure level--the normotensive non-dipper paradox. Chronobiol Int 30:87–98.
  • Higgins JP, Thompson SG. (2004). Controlling the risk of spurious findings from meta-regression. Stat Med 23:1663–82.
  • Higgins JP, Thompson SG, Spiegelhalter DJ. (2009). A re-evaluation of random-effects meta-analysis. J R Stat Soc Ser A Stat Soc 172:137–59.
  • Higuchi S, Motohashi Y, Ishibashi K, Maeda T. (2007). Influence of eye colors of Caucasians and Asians on suppression of melatonin secretion by light. Am J Physiol Regul Integr Comp Physiol 292:R2352–6.
  • Hill SM, Belancio VP, Dauchy RT, Xiang S, et al. (2015). Melatonin: an inhibitor of breast cancer. Endocr Relat Cancer 22:R183–204.
  • Hurd MW, Ralph MR. (1998). The significance of circadian organization for longevity in the golden hamster. J Biol Rhythms 13:430–6.
  • Hurley S, Goldberg D, Bernstein L, et al. (2015). Sleep duration and cancer risk in women. Cancer Causes Control 26:1037–45.
  • IARC (2010). IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Volume 98. Painting, Firefighting and Shiftwork. Lyon, France.
  • IARC W. (2006). Preamble. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Lyon, France.
  • Irwin M. (2002). Effects of sleep and sleep loss on immunity and cytokines. Brain Behav Immun 16:503–12.
  • Jagannath A, Butler R, Godinho SI, Couch Y, et al. (2013). The CRTC1-SIK1 pathway regulates entrainment of the circadian clock. Cell 154:1100–11.
  • Jiao L, Duan Z, Sangi-Haghpeykar H, Hale L, et al. (2013). Sleep duration and incidence of colorectal cancer in postmenopausal women. Br J Cancer 108:213–21.
  • Jung-Hynes B, Huang W, Reiter RJ, Ahmad N. (2010). Melatonin resynchronizes dysregulated circadian rhythm circuitry in human prostate cancer cells. J Pineal Res 49:60–8.
  • Kakizaki M, Inoue K, Kuriyama S, Sone T, et al. (2008). Sleep duration and the risk of prostate cancer: the Ohsaki Cohort Study. Br J Cancer 99:176–8.
  • Kakizaki M, Kuriyama S, Sone T, Ohmori-Matsuda K, et al. (2008). Sleep duration and the risk of breast cancer: the Ohsaki Cohort Study. Br J Cancer 99:1502–5.
  • Kayumov L, Lowe A, Rahman SA, Casper RF, et al. (2007). Prevention of melatonin suppression by nocturnal lighting: relevance to cancer. Eur J Cancer Prev 16:357–62.
  • Kelleher FC, Rao A, Maguire A. (2014). Circadian molecular clocks and cancer. Cancer Lett 342:9–18.
  • Kim TW, Jeong JH, Hong SC. (2015). The impact of sleep and circadian disturbance on hormones and metabolism. Int J Endocrinol 2015:591729.
  • Knapp G, Hartung J. (2003). Improved tests for a random effects meta-regression with a single covariate. Stat Med 22:2693–710.
  • Knutson KL, Spiegel K, Penev P, Van Cauter E. (2007). The metabolic consequences of sleep deprivation. Sleep Med Rev 11:163–78.
  • Popper KR. (1935); Translated: Popper KR. The logic of scientific discovery. First English edition published 1959 by Hutchinson & Co. Logik der Forschung: Zur Erkenntnistheorie der modernen Naturwissenschaft Springer, Vienna, Austria.
  • Kundermann B, Krieg JC, Schreiber W, Lautenbacher S. (2004). The effect of sleep deprivation on pain. Pain Res Manag 9:25–32.
  • Kwon P, Lundin J, Li W, Ray R, et al. (2015). Night shift work and lung cancer risk among female textile workers in shanghai, china. J Occup Environ Hyg 12):334–41.
  • Landis CA, Savage MV, Lentz MJ, Brengelmann GL. (1998). Sleep deprivation alters body temperature dynamics to mild cooling and heating not sweating threshold in women. Sleep 21:101–8.
  • Laposky AD, Bass J, Kohsaka A, Turek FW. (2008). Sleep and circadian rhythms: key components in the regulation of energy metabolism. FEBS Lett 582: 142–51.
  • Lee S, Donehower LA, Herron AJ, Moore DD, Fu L. (2010). Disrupting circadian homeostasis of sympathetic signaling promotes tumor development in mice. PLoS One 5:e10995.
  • Li W, Ray RM, Thomas DB, Davis S, et al. (2015). Shift work and breast cancer among women textile workers in Shanghai, China. Cancer Causes Control 26:143–50.
  • Liang JA, Sun LM, Muo CH, Sung FC, et al. (2012). Non-apnea sleep disorders will increase subsequent liver cancer risk--a nationwide population-based cohort study. Sleep Med 13:869–74.
  • Lorton D, Lubahn CL, Estus C, Millar BA, et al. (2006). Bidirectional communication between the brain and the immune system: implications for physiological sleep and disorders with disrupted sleep. Neuroimmunomodulation 13:357–74.
  • Lu Y, Tian N, Yin J, Shi Y, et al. (2013). Association between sleep duration and cancer risk: a meta-analysis of prospective cohort studies. PLoS One 8:e74723.
  • Luo J, Sands M, Wactawski-Wende J, Song Y, et al. (2013). Sleep disturbance and incidence of thyroid cancer in postmenopausal women the Women's Health Initiative. Am J Epidemiol 177:42–9.
  • Luojus MK, Lehto SM, Tolmunen T, Erkkila AT, et al. (2014). Sleep duration and incidence of lung cancer in ageing men. BMC Public Health 14:295.
  • Lyssenko V, Nagorny CL, Erdos MR, Wierup N, et al. (2009). Common variant in MTNR1B associated with increased risk of type 2 diabetes and impaired early insulin secretion. Nature genetics 41:82–8.
  • Maemura K, Takeda N, Nagai R. (2007). Circadian rhythms in the CNS and peripheral clock disorders: role of the biological clock in cardiovascular diseases. J Pharmacol Sci 103:134–8.
  • Markt SC, Grotta A, Nyren O, Adami HO, et al. (2015). Insufficient Sleep and Risk of Prostate Cancer in a Large Swedish Cohort. Sleep 1:1405–10.
  • McElroy JA, Newcomb PA, Titus-Ernstoff L, Trentham-Dietz A, et al. (2006). Duration of sleep and breast cancer risk in a large population-based case-control study. J Sleep Res 15:241–9.
  • Mediavilla MD, Sanchez-Barcelo EJ, Tan DX, Manchester L, et al. (2010). Basic mechanisms involved in the anti-cancer effects of melatonin. Curr Med Chem 17:4462–81.
  • Million Women Study Collaborative G. (1999). The Million Women Study: design and characteristics of the study population. The Million Women Study Collaborative Group. Breast Cancer Res 1:73–80.
  • Moore RY. (1973). Retinohypothalamic projection in mammals: a comparative study. Brain Research 49:403–9.
  • Moore RY, Klein DC. (1974). Visual pathways and the central neural control of a circadian rhythm in pineal serotonin N-acetyltransferase activity. Brain Res 71:17–33.
  • Morfeld P, McCunney RJ. (2009). Carbon black and lung cancer-testing a novel exposure metric by multi-model inference. Am J Ind Med 52:890–9.
  • Novati A, Roman V, Cetin T, Hagewoud R, et al. (2008). Chronically restricted sleep leads to depression-like changes in neurotransmitter receptor sensitivity and neuroendocrine stress reactivity in rats. Sleep 31:1579–85.
  • Odegaard AO, Koh WP, Yuan JM. (2013). Combined lifestyle factors and risk of incident colorectal cancer in a Chinese population. Cancer Prev Res (Phila) 6:360–7.
  • Parent ME, El-Zein M, Rousseau MC, Pintos J, et al. (2012). Night work and the risk of cancer among men. Am J Epidemiol 176:751–9.
  • Philip, P. and T. Akerstedt (2006). Transport and industrial safety, how are they affected by sleepiness and sleep restriction? Sleep Med Rev 10(5): 347–356.
  • Pilcher JJ, Lambert B. J, Huffcutt AI. (2000). Differential effects of permanent and rotating shifts on self-report sleep length: a meta-analytic review. Sleep 23:155–63.
  • Pinheiro SP, Schernhammer ES, Tworoger SS, Michels KB. (2006). A prospective study on habitual duration of sleep and incidence of breast cancer in a large cohort of women. Cancer Res 66:5521–5.
  • Portaluppi, F. and M. H. Smolensky (2010). Perspectives on the chronotherapy of hypertension based on the results of the MAPEC study. Chronobiol Int 27(8): 1652–1667.
  • Pronk A, Ji BT, Shu XO, Xue S, et al. (2010). Night-shift work and breast cancer risk in a cohort of Chinese women. Am J Epidemiol 171):953–9.
  • Qian X, Brinton LA, Schairer C, Matthews CE. (2015). Sleep duration and breast cancer risk in the Breast Cancer Detection Demonstration Project follow-up cohort. Br J Cancer 112:567–71.
  • Ralph MR, Foster RG, Davis FC, Menaker M. (1990). Transplanted suprachiasmatic nucleus determines circadian period. Science 247:975–8.
  • Ramin C, Devore EE, Pierre-Paul J, Duffy JF, et al. (2013). Chronotype and breast cancer risk in a cohort of US nurses. Chronobiol Int 30:1181–6.
  • Reiter RJ. (1991). Melatonin: the chemical expression of darkness. Mol Cell Endocrinol 79:C153–8.
  • Reiter RJ. (1993). The melatonin rhythm: both a clock and a calendar. Experientia 49: 654–64.
  • Reiter RJ, Tan DX, Erren TC, Fuentes-Broto L, et al. (2009). Light-mediated perturbations of circadian timing and cancer risk: a mechanistic analysis. Integr Cancer Ther 8:354–60.
  • Reiter RJ, Tan DX, Madrid JA, Erren TC. (2012). When the circadian clock becomes a ticking time bomb. Chronobiol Int 29:1286–7.
  • Riley RD, Higgins JP, Deeks JJ. (2011). Interpretation of random effects meta-analyses. BMJ 342:d549.
  • Roehrs T, Hyde M, Blaisdell B, Greenwald M, Roth T. (2006). Sleep loss and REM sleep loss are hyperalgesic. Sleep 29:145–51.
  • Roenneberg T. (2013). Chronobiology: the human sleep project. Nature 498:427–8.
  • Roenneberg T, Wirz-Justice A, Merrow M. (2003). Life between clocks: daily temporal patterns of human chronotypes. J Biol Rhythms 18:80–90.
  • Sahar S, Sassone-Corsi P. (2009). Metabolism and cancer: the circadian clock connection. Nat Rev Cancer 9:886–96.
  • Schernhammer ES, Feskanich D, Liang G, Han J. (2013). Rotating night-shift work and lung cancer risk among female nurses in the United States. Am J Epidemiol 178:1434–41.
  • Schernhammer ES, Kroenke CH, Laden F, Hankinson SE. (2006). Night work and risk of breast cancer. Epidemiology 17:108–11.
  • Schernhammer ES, Laden F, Speizer FE, Willett WC, et al. (2001). Rotating night shifts and risk of breast cancer in women participating in the nurses' health study. J Natl Cancer Inst 93:1563–8.
  • Schernhammer ES, Laden F, Speizer FE, Willett WC, et al. (2003). Night-shift work and risk of colorectal cancer in the nurses' health study. J Natl Cancer Inst 95:825–8.
  • Scott LD, Hwang WT, Rogers AE, Nysse T, et al. (2007). The relationship between nurse work schedules, sleep duration, and drowsy driving. Sleep 30:1801–7.
  • Shochat T, Haimov I, Lavie P. (1998). Melatonin--the key to the gate of sleep. Ann Med 30:109–14.
  • Sigurdardottir LG, Markt SC, Rider JR, Haneuse S, et al. (2015). Urinary melatonin levels, sleep disruption, and risk of prostate cancer in elderly men. Eur Urol 67:191–4.
  • Sigurdardottir LG, Valdimarsdottir UA, Mucci LA, Fall K, et al. (2013). Sleep disruption among older men and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 22:872–9.
  • Simko F, Pechanova O. (2009). Potential roles of melatonin and chronotherapy among the new trends in hypertension treatment. J Pineal Res 47:127–33.
  • Smolensky MH, Sackett-Lundeen LL, Portaluppi F. (2015). Nocturnal light pollution and underexposure to daytime sunlight: Complementary mechanisms of circadian disruption and related diseases. Chronobiol Int 32:1029–48.
  • StataCorp. (2014). Release 13. Statistical Software, College Station, TX: StataCorp LP.
  • Sterne JAC, Newton HJ, Cox NJ. (2009). Meta-analysis in stata: an updated collection from the stata journal, Stata Press: College Station, Texas.
  • Straif K, Baan R, Grosse Y, Secretan B, et al. (2007). Carcinogenicity of shift-work, painting, and fire-fighting. Lancet Oncol 8:1065–6.
  • Sturgeon SR, Luisi N, Balasubramanian R, Reeves KW. (2012). Sleep duration and endometrial cancer risk. Cancer Causes Control 23:547–53.
  • Sutton AJ, Abrams KR, Jones DR, Sheldon TA, et al. (2000). Methods for meta-analysis in medical research, John Wiley & Sons Ltd.: West Sussex, England.
  • Toh KL, Jones CR, He Y, Eide EJ, et al. (2001). An hPer2 phosphorylation site mutation in familial advanced sleep phase syndrome. Science 291:1040–3.
  • Ursin R, Bjorvatn B, Holsten F. (2005). Sleep duration, subjective sleep need, and sleep habits of 40- to 45-year-olds in the Hordaland Health Study. Sleep 28:1260–9.
  • Verkasalo PK, Lillberg K, Stevens RG, Hublin C, et al. (2005). Sleep duration and breast cancer: a prospective cohort study. Cancer Res 65:9595–600.
  • Viswanathan AN, Hankinson SE, Schernhammer ES. (2007). Night shift work and the risk of endometrial cancer. Cancer Res 67:10618–22.
  • Vogtmann E, Levitan EB, Hale L, Shikany JM, et al. (2013). Association between sleep and breast cancer incidence among postmenopausal women in the Women's Health Initiative. Sleep 36:1437–44.
  • von Ruesten A, Weikert C, Fietze I, Boeing H. (2012). Association of sleep duration with chronic diseases in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam study. PLoS One 7:e30972.
  • Wang P, Ren FM, Lin Y, Su FX, et al. (2015). Night-shift work, sleep duration, daytime napping, and breast cancer risk. Sleep Med 16:462–8.
  • Weiderpass E, Sandin S, Inoue M, Shimazu T, et al. (2012). Risk factors for epithelial ovarian cancer in Japan - results from the Japan Public Health Center-based Prospective Study cohort. Int J Oncol 40:21–30.
  • Wetterberg L, Halberg F, Tarquini B, Cagnoni M, et al. (1979). Circadian variation in urinary melatonin in clinically healthy women in Japan and the United States of America. Experientia 35:416–9.
  • Wicht H, Korf HW, Ackermann H, Ekhart D, et al. (2014). Chronotypes and rhythm stability in mice. Chronobiol Int 31:27–36.
  • Wood PA, Yang X, Hrushesky WJ. (2009). Clock genes and cancer. Integr Cancer Ther 8:303–8.
  • Wu AH, Stanczyk FZ, Wang R, Koh WP, et al. (2013). Sleep duration, spot urinary 6-sulfatoxymelatonin levels and risk of breast cancer among Chinese women in Singapore. Int J Cancer 132:891–6.
  • Wulff K, Gatti S, Wettstein JG, Foster RG. (2010). Sleep and circadian rhythm disruption in psychiatric and neurodegenerative disease. Nat Rev Neurosci 11:589–99.
  • Xin Z, Jiang S, Jiang P, Yan X, et al. (2015). Melatonin as a treatment for gastrointestinal cancer: a review. J Pineal Res 58:375–87.
  • Yang C, Winkelman JW. (2006). Clinical significance of sleep EEG abnormalities in chronic schizophrenia. Schizophrenia research 82:251–60.
  • Young ME, Bray MS. (2007). Potential role for peripheral circadian clock dyssynchrony in the pathogenesis of cardiovascular dysfunction. Sleep Med 8:656–67.
  • Yu EA, Weaver DR. (2011). Disrupting the circadian clock: gene-specific effects on aging, cancer, and other phenotypes. Aging (Albany NY) 3:479–93.
  • Zhang HM, Zhang Y. (2014). Melatonin: a well-documented antioxidant with conditional pro-oxidant actions. J Pineal Res 57:131–46.
  • Zhang X, Giovannucci EL, Wu K, Gao X, et al. (2013). Associations of self-reported sleep duration and snoring with colorectal cancer risk in men and women. Sleep 36:681–8.
  • Zisapel N. (2001). Circadian rhythm sleep disorders: pathophysiology and potential approaches to management. CNS Drugs 15: 311–28.ADDIN.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.